Knowledge Distillery

Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study

COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival

CoV2 preS dTM is a stabilised pre-fusion spike protein vaccine produced in a baculovirus expression system being developed against SARS-CoV-2. In this…

Our highlighted selection of recent papers from the scientific press for January 2022

The mental health impact of the COVID-19 pandemic on people with and without depressive, anxiety, or obsessive-compulsive disorders: a longitudinal…

Persistent visual dysfunction following PRES due to COVID-19: Case series and literature review

In this article the authors examined vaccine effectiveness among health care workers at the Hadassah Hebrew University Medical Center (HHUMC), a…

Our highlighted selection of recent papers from the scientific press for February 2022

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil,…

Risk and outcomes of COVID-19 in patients with multiple sclerosis

Since the start of the vaccination campaign, the development of COVID-19 has been reported in persons who have received one or both doses of mRNA-1273…

Our highlighted selection of Covid-related Literature Reviews from the scientific press for February 2022.